CBDIX Fees and Costs — Calvert Bond Fund, Class I
Data updated: 2026-08-27
The net expense ratio is 0.53%: a 0.41% management fee plus 0.14% other expenses, less a 0.02% fee waiver. There are no sales loads or redemption fees. In fiscal 2025 the fund paid $62 in broker commissions, and portfolio turnover was 326%.
CBDIX Fees and Expenses
Annual operating expenses and sales charges of CBDIX. Prospectus, as of September 30, 2025.
| Annual operating expenses | |
|---|---|
| Management fee | 0.41% |
| 12b-1 fee | 0.00% |
| Other expenses | 0.14% |
| Gross expense ratio | 0.55% |
| Fee waiver | −0.02% |
| Net expense ratio | 0.53% |
| Sales charges | |
|---|---|
| Max front load | 0.00% |
| Max deferred load | 0.00% |
| Redemption fee | — |
| Expense limitation in place (N-CEN) | Yes |
| Fees waived or reduced during the year | Yes |
| Waived fees subject to recoupment | No |
CBDIX Costs Over Time
On $10,000 invested in CBDIX, assuming 5% a year before costs, total costs come to $335 over 5 years, cutting the return by 0.56% a year. Illustration, not a forecast: it assumes today's net expense ratio throughout (a fee waiver may end).
| $10,000 invested | Sell after 1 year | Sell after 3 years | Sell after 5 years |
|---|---|---|---|
| Value before costs | $10,500 | $11,576 | $12,763 |
| Fund expenses (net expense ratio 0.53%) | $56 | $174 | $304 |
| Lost growth on money paid in costs | $0 | $9 | $31 |
| Total costs | $56 | $183 | $335 |
| Value after costs | $10,444 | $11,393 | $12,428 |
| Impact on return, per year | 0.56% | 0.56% | 0.56% |
CBDIX Trading Costs
Brokerage costs reported on SEC Form N-CEN for the fiscal year ending September 30, 2025.
- Explicit cost rate (commissions ÷ average net assets): —
- Total broker commissions: $62
- Bought from dealers (principal trades, not a cost): $30.2B
- Portfolio turnover (prospectus): 326%
- Securities on loan, average value: $53.5M
- Net income from securities lending: $234K (0.006% of average net assets)
CBDIX Agency Brokers
Commissions paid.
| Broker | Amount | Share |
|---|---|---|
| Goldman Sachs & Co. LLC | $62 | 100.00% |
CBDIX Dealer Counterparties
Securities bought directly from dealers (principal trades).
| Broker | Amount | Share |
|---|---|---|
| Wells Fargo Securities, LLC | $18.0B | 62.04% |
| State Street Global Markets, LLC | $3.3B | 11.30% |
| Goldman Sachs & Co. LLC | $2.5B | 8.79% |
| J.P. Morgan Securities LLC | $1.6B | 5.37% |
| BNP Paribas Securities Corp. | $1.2B | 4.24% |
| BofA Securities, Inc. | $861.3M | 2.97% |
| Mizuho Securities USA LLC | $520.8M | 1.80% |
| Barclays Capital Inc. | $416.1M | 1.44% |
| Nomura Securities International, Inc. | $351.0M | 1.21% |
| Citigroup Global Markets Inc. | $243.5M | 0.84% |
Calvert Bond Fund Share Classes
Net expense ratio and maximum front-end load of each share class, cheapest first.
| Ticker | Class | Net expense ratio | Front load |
|---|---|---|---|
| CBORX | Class R6 | 0.46% | none |
| CBDIX | Class I | 0.53% | none |
| CSIBX | Class A | 0.73% | 3.25% |
| CSBCX | Class C | 1.53% | none |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.